Multivariable Cox model for OS and DFS
| . | OS . | DFS . | ||||||
|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P . | |||
| All patients | ||||||||
| Age: continuous variable | 1.01 | 0.99 | 1.03 | .187 | 0.98 | 0.95 | 1.02 | .578 |
| Sex: male vs female | 0.93 | 0.5 | 1.73 | .824 | 1.07 | 0.4 | 2.5 | .987 |
| WBC, ×109/L: continuous variable | 2.3 | 1.7 | 5.03 | <.001 | 3.44 | 1.54 | 7.66 | .002 |
| BAALC expression: high vs low | 1.69 | 0.88 | 3.24 | .11 | 5.26 | 1.52 | 18.2 | .009 |
| Low-risk patients | ||||||||
| Age: continuous variable | 0.95 | 0.88 | 1.03 | .236 | —* | —* | —* | |
| Sex: male vs female | 1.08 | 0.19 | 6.05 | .928 | —* | —* | —* | |
| BAALC expression: high vs low | 3.51 | 0.4 | 30.7 | .256 | —* | —* | —* | |
| Intermediate-risk patients | ||||||||
| Age: continuous variable | 0.99 | 0.93 | 1.05 | .845 | 0.96 | 0.9 | 1.02 | .248 |
| Sex: male vs female | 1.29 | 0.26 | 6.42 | .752 | 2.24 | 0.41 | 12.2 | .35 |
| BAALC expression: high vs low | 4.29 | 0.49 | 36.8 | .184 | 4.38 | 0.51 | 37.6 | .177 |
| High-risk patients | ||||||||
| Age: continuous variable | 1.03 | 1.01 | 1.05 | .025 | 1.09 | 0.96 | 1.05 | .684 |
| Sex: male vs female | 1.06 | 0.51 | 2.2 | .87 | 0.87 | 0.26 | 2.83 | .819 |
| BAALC expression: high vs low | 1.26 | 0.6 | 2.64 | .53 | 5.3 | 1.14 | 24.5 | .033 |
| . | OS . | DFS . | ||||||
|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P . | |||
| All patients | ||||||||
| Age: continuous variable | 1.01 | 0.99 | 1.03 | .187 | 0.98 | 0.95 | 1.02 | .578 |
| Sex: male vs female | 0.93 | 0.5 | 1.73 | .824 | 1.07 | 0.4 | 2.5 | .987 |
| WBC, ×109/L: continuous variable | 2.3 | 1.7 | 5.03 | <.001 | 3.44 | 1.54 | 7.66 | .002 |
| BAALC expression: high vs low | 1.69 | 0.88 | 3.24 | .11 | 5.26 | 1.52 | 18.2 | .009 |
| Low-risk patients | ||||||||
| Age: continuous variable | 0.95 | 0.88 | 1.03 | .236 | —* | —* | —* | |
| Sex: male vs female | 1.08 | 0.19 | 6.05 | .928 | —* | —* | —* | |
| BAALC expression: high vs low | 3.51 | 0.4 | 30.7 | .256 | —* | —* | —* | |
| Intermediate-risk patients | ||||||||
| Age: continuous variable | 0.99 | 0.93 | 1.05 | .845 | 0.96 | 0.9 | 1.02 | .248 |
| Sex: male vs female | 1.29 | 0.26 | 6.42 | .752 | 2.24 | 0.41 | 12.2 | .35 |
| BAALC expression: high vs low | 4.29 | 0.49 | 36.8 | .184 | 4.38 | 0.51 | 37.6 | .177 |
| High-risk patients | ||||||||
| Age: continuous variable | 1.03 | 1.01 | 1.05 | .025 | 1.09 | 0.96 | 1.05 | .684 |
| Sex: male vs female | 1.06 | 0.51 | 2.2 | .87 | 0.87 | 0.26 | 2.83 | .819 |
| BAALC expression: high vs low | 1.26 | 0.6 | 2.64 | .53 | 5.3 | 1.14 | 24.5 | .033 |
Multivariable Cox modeling was hampered by the small number of events (relapses) in the low-risk group; therefore, no statistical analysis was performed.